Core Viewpoint - American Hotel Income Properties REIT LP (AHIP) is set to discuss its fourth quarter results, highlighting forward-looking information that may significantly differ from actual financial outcomes due to various risks and uncertainties [1][2]. Financial Performance - The call will include discussions on non-IFRS financial measures, with references to prior year's operating results based on AHIP's portfolio of 31 properties [3].

2025 ANNUAL RESULTS MARCH 19, 2026 Samsonite Group S.A. Stock Code: 1910 DISCLOSURE STATEMENT This Presentation contains forward-looking statements. Forward-looking statements reflect our current views with respect to future events and performance. These statements may discuss, among other things, the Company's net sales, gross margin, operating profit, adjusted net income, adjusted EBITDA, adjusted EBITDA margin, cash flow, adjusted free cash flow, ratio, liquidity and capital resources, potential impairme ...

Core Insights - Diversified Royalty Corp. reported financial results for Q4 2025 and the year ended December 31, 2025, highlighting a positive performance from its royalty partners with an overall weighted average organic royalty growth of 3.0% in Q4 2025 and 4.1% for the full year [3][7]. Financial Performance - Revenue for Q4 2025 was $19.1 million, an increase of 11.9% compared to $17.0 million in Q4 2024. For the year ended December 31, 2025, revenue reached $70.8 million, up 8.9% from $64.9 million in 2024 [7][9]. - Adjusted revenue for Q4 2025 was $20.4 million, reflecting an 11.2% increase from $18.4 million in Q4 2024. For the full year, adjusted revenue was $76.1 million, up 8.4% from $70.2 million in 2024 [7][9]. - Distributable cash for Q4 2025 was $13.6 million, a 7.9% increase from $12.6 million in Q4 2024. For the year, distributable cash was $50.5 million, up 12.7% from $44.8 million in 2024 [23][24]. Royalty Partner Performance - Mr. Lube + Tires, the largest royalty partner, achieved same-store sales growth (SSSG) of 7.2% in Q4 2025 and 9.5% for the year, driven by increased tire and maintenance sales [11]. - Stratus reported royalty income of $2.4 million for Q4 2025, with a fixed royalty payment increasing at a rate of 5% annually until November 2026 [12]. - Nurse Next Door generated a royalty entitlement of $1.4 million in Q4 2025, with a fixed growth rate of 2.0% per annum [13]. - Oxford Learning Centres achieved SSSG of 3.7% in Q4 2025, reflecting solid performance [17]. - Mr. Mikes experienced a slight decline in SSSG of -1.1% in Q4 2025 due to lower guest traffic [15]. - AIR MILES® saw a decline in royalty income of 7.9% in Q4 2025, attributed to ongoing softness in the rewards program [18]. Dividend and Payout Ratios - The payout ratio for Q4 2025 was 87.1%, compared to 82.3% in Q4 2024. For the year, the payout ratio was 88.1%, down from 90.0% in 2024 [26]. - Dividends declared per share were $0.0696 for Q4 2025 and $0.2634 for the year, reflecting an increase from $0.0625 and $0.2487 in the respective prior periods [26]. Net Income - Net income for Q4 2025 was $11.0 million, significantly up from $4.0 million in Q4 2024. For the year, net income was $36.7 million, compared to $26.6 million in 2024 [28].

Core Viewpoint - Wallbox has announced its fourth quarter and full year 2025 financial results, indicating significant developments in its performance and future outlook [2][3]. Financial Performance - The company presented unaudited financial statements in IFRS format, reflecting management's best assessment of actual results [5]. - Non-IFRS financial measures were utilized during the call, with reconciliations available in the presentation on the investor website [5]. Leadership Involvement - The earnings call featured key executives, including the CEO Enric Asuncion and CFO Isabel Lopez Trujillo, highlighting the leadership's engagement in discussing the company's performance [3].

Core Insights - SOPHiA GENETICS reported a fourth quarter revenue of $21.7 million, a 22% increase year-over-year, and a full-year revenue of $77.3 million, up 19% year-over-year, indicating strong growth momentum [1][2] - The company experienced an IFRS net loss of $19.2 million in Q4 2025, a 27% increase from the previous year, and a full-year net loss of $79.0 million, up 26% year-over-year [1][2] - Adjusted gross margin improved to 74.2% in FY 2025, reflecting a 140 basis point increase year-over-year, despite a 40% increase in total terabytes processed by the platform [1][2] Financial Performance - Q4 2025 IFRS net loss: $19.2 million, up 27% YoY; Adjusted EBITDA loss: $9.9 million, up 9% YoY [1] - FY 2025 IFRS net loss: $79.0 million, up 26% YoY; Adjusted EBITDA loss: $41.5 million, up 3% YoY [1] - Gross margin for Q4 2025: 67.7% reported, 73.9% adjusted; FY 2025 gross margin: 67.4% reported, 74.2% adjusted [1][2] Business Highlights - The company signed 124 new core genomics customers in FY 2025, a significant increase from 92 in FY 2024, and achieved a net dollar retention rate of 115% [1][2] - New customer signings included major health systems in the U.S. expected to analyze 60,000 patients annually [1][2] - The company performed over 391,000 analyses in FY 2025, with a record 105,000 analyses in Q4 2025 [1][2] Growth Drivers - Anticipated growth in 2026 will be driven by continued execution in the U.S. market, expansion of the Liquid Biopsy application MSK-ACCESS®, and renewed momentum in the BioPharma business [1][2] - The company expects to approach adjusted EBITDA breakeven by the end of 2026 and achieve positive adjusted EBITDA in the second half of 2027 [1][2] Strategic Collaborations - A strategic collaboration was announced with MD Anderson Cancer Center to co-develop advanced multimodal oncology testing solutions [1][2] - Continued partnerships with Myriad Genetics and A.D.A.M. Innovations aim to develop MSK-ACCESS® into a regulated global companion diagnostic assay [1][2]

Core Insights - Pet Valu Holdings Ltd. reported strong financial results for Q4 and fiscal year 2025, with significant revenue growth and operational execution despite competitive pressures [1][4]. Fourth Quarter Highlights - System-wide sales reached $423.7 million, a 9.2% increase compared to Q4 2024, with same-store sales growth of 0.3% [6][8]. - Revenue for Q4 was $326.4 million, up 10.6% from $295.1 million in Q4 2024 [7]. - Adjusted EBITDA was $74.6 million, representing a 9.4% increase, with an EBITDA margin of 22.9% [14]. - Net income for Q4 was $29.4 million, a 1.6% increase from $28.9 million in Q4 2024 [13]. - The company opened 14 new stores, bringing the total to 863 [6]. Fiscal Year Highlights - Total revenue for fiscal 2025 was $1,175.6 million, a 7.1% increase from $1,097.2 million in fiscal 2024 [22]. - Same-store sales growth for the fiscal year was 1.6%, driven by a 1.7% increase in average spend per transaction [23]. - Adjusted EBITDA for the fiscal year was $257.1 million, up 4.1% from $247.1 million in fiscal 2024 [29]. - Net income for fiscal 2025 was $97.8 million, an 11.9% increase from $87.4 million in fiscal 2024 [28]. 2026 Outlook - The company anticipates revenue growth of 2% to 4% for fiscal 2026, with flat to slight expansion in Adjusted EBITDA margin [4][36]. - Plans to open approximately 40 new stores and maintain competitiveness through operational efficiencies [36]. - Expected growth in Adjusted Net Income per Diluted Share in the mid to high single-digits [36].

Fourth Quarter and Full Year 2025 2 March 2026 Forward looking statements and non-IFRS measures This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended ...

Codere Online Q4 2025 Earnings February 26, 2026 INFORMACION COLOR: R169 G103 B 171 R121 G192 B 0 R51 G63 B 72 Disclaimer This presentation (this "Presentation"), its contents and any information provided during the meeting to present this document are for discussion purposes only, and must not be relied upon for any purpose. This Presentation is not for release, publication or distribution, in whole or in part, in or into any jurisdiction where such distribution would be unlawful. Certain terms used throug ...

4Q'25 Results February 2026 Disclaimer This presentation was prepared by Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (d/b/a Volaris, the "Company") with the purpose of providing interested parties certain financial and other information about the Company. This presentation is solely for discussion purposes and highlights basic information about the Company. Because it is a summary, it does not contain all the information that you should consider before investing in the securities of the Company. ...

Q4 AND YEAR END 2025 RESULTS CONFERENCE CALL February 20, 2026 Skouries Forward Looking Statement Definitions and Photos: Capitalized terms used in this presentation but not otherwise defined herein have the meanings ascribed thereto in the Management's Discussion and Analysis dated February 19, 2026 of Eldorado Gold Corporation for the three and twelve months ended December 31, 2025 (the "MD&A"). Photos shown within the presentation were taken as recently as February 14, 2026. Reporting Currency All amount ...